鄰近類別 專利 [0/1] 會議論文/會議摘要 [1/1] 類別統計 近3年內發表的文件:11(50.00%) 含全文筆數:22(100.00%) 文件下載次數統計 下載大於0次:22(100.00%) 下載大於100次:18(81.82%) 檔案下載總次數:4743(99.73%) 最後更新時間: 2025-04-19 15:23 上傳排行 資料載入中..... 下載排行 資料載入中..... 最近上傳 Tumor cell-derived ISG15 promotes f... Upregulation of cathepsin S express... Synthesis, anticancer evaluation an... Advancing precision therapy for col... Macrophage-mediated controlled rele... Targeting cathepsin S promotes acti... Lysosomal-targeted doxorubicin deli... How to deal with frenemy NRF2: Targ... Synthesis and structure–activity re... The synergistic inhibition of coron...

跳至: (選擇年份) 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (選擇月份) January February March April May June July August September October November December 或輸入年份:

由新到舊排序 由最舊的開始

顯示項目1-10 / 22. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目

日期	題名	關聯
2025-03-11	Tumor cell-derived ISG15 promotes fibroblast recruitment in oral squamous cell carcinoma via CD11a-dependent glycolytic reprogramming	Oncogenesis. 2025 Mar 11;14:Article number 6.
2025-03-05	Upregulation of cathepsin S expression contributes to neuronal damage following kainic acid-induced status epilepticus	Journal of Neurochemistry. 2025 Mar 05;169(3):Article number e70037.
2025-02-03	Synthesis, anticancer evaluation and structure-activity relationship of Taiwanin a derivatives	Chemistry of Natural Compounds. 2025 Feb 03;61:11-18.
2025-01	Advancing precision therapy for colorectal cancer: Developing clinical indications for multi-target kinase inhibitor BPR1J481 using patient-derived xenograft models	Pharmacological Research. 2025 Jan;211:Article number 107556.
2024-06-24	Macrophage-mediated controlled release of cysteine protease inhibitor from PLGA-PEG/hydroxyapatite microspheres for targeting cathepsin S in Alzheimer's disease	European Polymer Journal. 2024 Jun 24;214:Article number 113151.
2024-05-09	Targeting cathepsin S promotes activation of OLF1-BDNF/TrkB axis to enhance cognitive function	Journal of Biomedical Science. 2024 May 09;31:Article number 46.
2023-11	Lysosomal-targeted doxorubicin delivery using RBC-derived vesicles to overcome drug-resistant cancer through mitochondrial-dependent cell death	Pharmacological Research. 2023 Nov;197:Article number 106945.
2023-03-28	Synthesis and structure–activity relationship of salvinal derivatives as potent microtubule inhibitors	International Journal of Molecular Sciences. 2023 Mar 28;24(7):Article number 6386.
2023-02-28	How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy	Journal of Food and Drug Analysis. 2023 Feb 28;31(3):387-407.
2023-02-03	MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition	Journal of Experimental and Clinical Cancer Research. 2023 Feb 3;42:Article number 40.

顯示項目1-10 / 22. (共3頁) 1 2 3 > >> 每頁顯示[10|25|50]項目